Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,146.00
Bid: 1,142.00
Ask: 1,146.00
Change: 14.00 (1.24%)
Spread: 4.00 (0.35%)
Open: 1,130.00
High: 1,150.00
Low: 1,130.00
Prev. Close: 1,132.00
CVSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

23 Jul 2013 08:09

RNS Number : 9168J
CVS Group plc
23 July 2013
 

 

23 July 2013

 

CVS Group plc (the "Group")

 

Trading Update

 

The Board is pleased to announce that the results for the year ended 30 June 2013 will be in line with market expectations and will be released on Tuesday 24 September 2013.

 

Total like-for-like Group turnover for the year showed growth of 3.4%. This growth was achieved despite sales being moderately impacted by snow during January (0.2% impact) and there being one fewer trading days in the second half of 2013 compared to 2012 (0.3% impact).

 

Good organic growth has been achieved in the core veterinary practices throughout the year. The period has seen growth of over 70% in the membership of loyalty schemes which now exceed 111,900 pets compared to 65,500 at this time last year. At current run rates loyalty schemes are contributing over 9% of the total revenue from practices.

 

It is pleasing to report that there has been significant growth in the e-commerce operations. Animed Direct is currently generating some £6.7 million of annualised revenue, compared with £3.5 million at 30 June 2012 and continues to show significant growth opportunities. In addition, five on-line practice shops were opened during the year.

 

Internally funded acquisition activity has continued to play an important part in the Group's strategy. In addition to the three practices and the pet crematorium acquired in the first half of the year, four practices, Cranmore (two sites in Chester), Archway (Petersfield), Alver (three sites in and around Gosport) and Filham Park (Ivy Bridge, Devon) were acquired during the second half. These four acquisitions extend the Group's practice division's operations and the sites are an excellent geographic fit with the Group's existing surgeries. All of the acquisitions have been successfully integrated into the Group. Subsequent to the year end on 15 July 2013, Crescent (Melton Mowbray) was acquired. Based on the last financial year prior to acquisition the aggregate turnover derived from these five additional practices amounted to £8.3 million.

 

As well as small animal services, the Filham Park and Crescent practices both include some equine activities, extending our offering in this area. The Cranmore acquisition includes a referrals centre and on 1 July 2013 Professor John Innes joined us as a Referrals Director to run and expand our referrals business. John has been a leading figure in the academic and animal orthopaedic worlds for many years; most recently he has been closely involved in developing clinical services at the University of Liverpool. Not only will John bring world class experience in orthopaedics to the Group, but he will also bring experience and expertise in the development of referral services.

 

In total the Group now operates 248 veterinary practices across the UK, an on-line dispensary and 11 on-line practice shops, 5 diagnostic laboratories and 2 pet crematoria. CVS continues to be the UK's largest operator in a highly fragmented market.

 

For further enquiries please contact:

 

CVS Group plc: 01379 644 288

Simon Innes - Chief Executive

Nick Perrin - Finance Director

 

N+1 Singer 020 7496 3000

Aubrey Powell

Graeme Summers

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGMGZNNFKGFZG
Date   Source Headline
26th Jan 20237:00 amRNSHalf year Trading Update
11th Jan 20234:31 pmRNSBlock Listing Interim Review and TVR Update
10th Jan 202312:24 pmRNSExercise of SAYE Options and PDMR Dealing
30th Dec 20227:00 amRNSExercise of Options and Total Voting Rights
20th Dec 20224:38 pmRNSExercise of Options and PDMR Dealing
30th Nov 20227:00 amRNSExercise of Options and Total Voting Rights
25th Nov 20224:22 pmRNSSAYE Option Scheme & PDMR Dealing
23rd Nov 20222:31 pmRNSResult of AGM
23rd Nov 20227:00 amRNSAGM Statement and Trading Update
8th Nov 20227:00 amRNSCapital Markets Day
31st Oct 20227:00 amRNSExercise of Options and Total Voting Rights
28th Oct 202210:22 amRNSAnnual Report, Notice of AGM & Dividend Timetable
12th Oct 202210:52 amRNSHolding(s) in Company
7th Oct 20227:00 amRNSDirector/PDMR Shareholding
30th Sep 20224:19 pmRNSLong Term Incentive Plan Awards and PDMR Dealing
30th Sep 20227:00 amRNSExercise of Options and Total Voting Rights
29th Sep 202210:34 amRNSHolding(s) in Company
28th Sep 20227:00 amRNSDirector/PDMR Shareholding
27th Sep 20224:19 pmRNSDirector/PDMR Shareholding
26th Sep 202211:56 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
22nd Sep 20227:00 amRNSFinal Results for the year ended 30 June 2022
31st Aug 20227:00 amRNSExercise of Options and Total Voting Rights
9th Aug 20229:30 amRNSHolding(s) in Company
29th Jul 20227:00 amRNSExercise of Options and Total Voting Rights
28th Jul 20227:00 amRNSTrading Update
13th Jul 20227:00 amRNSAppointment of Nominated Advisor and Joint Brokers
12th Jul 20227:00 amRNSBlock Listing Interim Review and TVR Update
1st Jul 20227:00 amRNSConclusion of CMA process, acquisition and trading
30th Jun 20227:00 amRNSExercise of Options and Total Voting Rights
13th Jun 20223:00 pmRNSPostponement to Capital Markets Day
8th Jun 20221:54 pmRNSHolding(s) in Company
31st May 20227:00 amRNSExercise of Options and Total Voting Rights
6th May 20227:00 amRNSAcquisition of Anton Vets
29th Apr 20227:00 amRNSExercise of Options and Total Voting Rights
31st Mar 20227:00 amRNSExercise of Options and Total Voting Rights
28th Mar 202210:47 amRNSHolding(s) in Company
24th Mar 20222:54 pmRNSDirector/PDMR Shareholding
24th Mar 202210:03 amRNSHolding(s) in Company
24th Mar 20227:00 amRNSInterim Results
21st Mar 20229:14 amRNSHolding(s) in Company
18th Mar 202210:17 amRNSHolding(s) in Company
3rd Mar 20228:38 amRNSHolding(s) in Company
28th Feb 20227:00 amRNSExercise of Options and Total Voting Rights
21st Feb 20225:37 pmRNSHolding(s) in Company
18th Feb 20227:15 amRNSCMA Update
3rd Feb 20229:43 amRNSHolding(s) in Company
31st Jan 20227:00 amRNSExercise of Options and Total Voting Rights
27th Jan 20227:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.